The Rebound-Risk Estimator is a feature the brand describes as an "educational estimate of post-medication rebound risk based on the habits and signals you log." The brand explicitly labels it as "behavioral nudges, not medical advice." Weight regain after GLP-1 discontinuation is a documented concern in published research - a 2025 systematic review and meta-analysis published in eClinicalMedicine confirmed that weight, HbA1c, and blood pressure consistently rebound after cessation
Water retention from sodium, hormones, travel, or even a hard workout can temporarily mask fat loss
She also reports stomach pain 2-3 times per week
However, common microvascular complications such as the threatening diabetic retinopathy (DR) have not only exacerbated the condition of diabetic patients but also significantly reduced their prognosis, and by 2020, the number of people with DR had exceeded 100 million globally, and is still on the rise [1, 2]
Un esempio il Kit di iniezione della retatrutide: la sostanza contenuta ancora in fase di sviluppo clinico e, pur non essendo omologata a livello internazionale, gi disponibile sul mercato nero
Can GLP-1 analogues be used for weight loss without having diabetes
